Vaccine mRNA Pfizer Moderna
Vaccine mRNA Pfizer Moderna

Booster protection in the US could soon expand to a much broader population, as a source says the US government likely will soon recommend them to people as young as 40 who received either Moderna or Pfizer’s Covid-19 vaccine.

“I believe it will happen,” the source familiar with the plan said, adding that there is “growing concern within the FDA” that US data is beginning to show more hospitalizations among people under age 65 who have been fully vaccinated.
 

Play